Etropal AD operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Etropal AD with three other
medical equipment manufacturers in Europe:
Safe Orthopaedics SA
sales of 3.66 million Euros [US$4.28 million]
of which 56%
was Direct Sales),
(3.38 million Euros [US$3.96 million]
of which 100%
was Implants and Surgical instruments), and
based in FRANCE
(4.85 million Euros [US$5.68 million]
During the second
quarter of 2021, sales at Etropal AD totalled
1.94 million Bulgarian Levas.
an increase of 58.8%
from the 1.22 million Bulgarian Levas in sales at the company during the second quarter of 2020.
This was the largest same quarter increase in sales since the fourth
quarter of 2017.
During the first two
quarters of 2021, sales totalled 4.55 million Bulgarian Levas, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Etropal AD were 7.46 million Bulgarian Levas (US$4.47 million).
increase of 9.5%
versus 2019, when the company's sales were 6.81 million Bulgarian Levas.
Despite this increase, sales are still
below the level achieved in 2018, when Etropal AD
reported sales of 8.30 million Bulgarian Levas.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Etropal AD had sales
of 7.91 million Bulgarian Levas.